The global immuno analyzers market size is expected to reach USD 39.5 billion by 2027 from USD 27.8 billion in 2021, at a CAGR of 6.8% during the forecast period. Immunoassay analyzers are the instruments which are used in clinical settings, hospitals or maybe the research organizations to run the biochemical tests to detect the concentration of samples. The market for immuno analyzers is growing due to the increased prevalence of disease outbreaks such as Zika and the rising incidence of chronic diseases such as hepatitis. Furthermore, advances in laboratory automation and integration, as well as preventative healthcare, are creating growth prospects for the global immuno analyzers market. Immunoassay analyzers are extensively used in clinical laboratories and hospitals to perform biochemical tests aimed at detecting and measuring the quantity of chemicals in samples. Small scale laboratories have a long time to adjust to changes in instrumentation due to factors such as system revaluation, staff training, procedure standardisation, and lengthy purchase processes. Manufacturers, on the other hand, are seeking to make more affordable analyzer systems or provide replacement benefits to create revenue. Companies operating in global immuno analyzers market are focusing on the new product developments and launches to strengthen their position. For instance In September 2014, Sysmex Corp. has launched Automated, compact Immunoassay System HISCL 800 for immunochemistry testing for increasingly diverse needs. Furthermore, companies also adapting the strategies such as acquisitions and collaboration to increase their product portfolio and market share. For instance, in March 2016, Diasorin S.p.A. has entered into the agreement to acquire Quest’s Focus Diagnostics, Inc. molecular diagnostic and immunodiagnostic products business.